Filter News
Area of Research
- (-) Nuclear Science and Technology (23)
- Advanced Manufacturing (2)
- Biology and Environment (14)
- Clean Energy (20)
- Computational Biology (1)
- Computational Engineering (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (15)
- Fusion Energy (9)
- Isotope Development and Production (1)
- Isotopes (5)
- Materials (28)
- Materials for Computing (6)
- National Security (5)
- Neutron Science (9)
- Nuclear Systems Modeling, Simulation and Validation (2)
- Supercomputing (27)
News Type
News Topics
- (-) Advanced Reactors (7)
- (-) Biomedical (2)
- (-) Nuclear Energy (20)
- 3-D Printing/Advanced Manufacturing (2)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (3)
- Isotopes (3)
- Materials Science (1)
- Molten Salt (3)
- Neutron Science (3)
- Physics (2)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.